Annual Report 2025
Units appear below each metric. Scroll to compare years
| Metric / unit | 2025Group | 2024Group | 2023Group | 2022Group | Source |
|---|---|---|---|---|---|
| Income statement | |||||
| RevenueUS$ million | 12,951 | 10,910 | 9,756 | 11,439 | PDF p. 7 |
| Gross profit 1US$ million | 1,900 | 1,567 | 1,395 | 2,579 | PDF p. 7 |
| EBITDA 2,3US$ million | 1,258 | 1,101 | 986 | 1,826 | PDF p. 7 |
| Underlying profit 3,4US$ million | 522 | 416 | 328 | 922 | PDF p. 7 |
| Net profit attributable to owners of the CompanyUS$ million | 400 | 365 | 198 | 782 | PDF p. 7 |
| Weighted average number of shares (million shares)million shares | 12,682 | 12,682 | 12,682 | 12,683 | PDF p. 7 |
| Underlying profit 4 per share (US$ cents)US$ cents per share | 4.12 | 3.28 | 2.58 | 7.27 | PDF p. 7 |
| Earnings per share (US$ cents)US$ cents per share | 3.16 | 2.87 | 1.56 | 6.17 | PDF p. 7 |
| Dividend per share for the current year’s underlying profit (S$ cents)S$ cents per share | 0.952 | 0.804 | 0.613 | 1.791 | PDF p. 7 |
| Financial position | |||||
| Total assetsUS$ million | 10,665 | 10,693 | 9,716 | 9,902 | PDF p. 7 |
| Total liabilitiesUS$ million | 4,938 | 5,315 | 4,537 | 4,648 | PDF p. 7 |
| Equity attributable to owners of the CompanyUS$ million | 5,415 | 5,102 | 4,926 | 5,001 | PDF p. 7 |
| Interest bearing debtUS$ million | 3,249 | 3,706 | 3,065 | 2,984 | PDF p. 7 |
| Cash, short-term investments, and liquid working capital 5US$ million | 2,960 | 3,141 | 2,674 | 2,841 | PDF p. 7 |
| Net debt 6US$ million | 289 | 565 | 391 | 142 | PDF p. 7 |
| Financial ratios | |||||
| Gross margin% | 14.7 | 14.4 | 14.3 | 22.5 | PDF p. 7 |
| EBITDA 2,3 margin% | 9.7 | 10.1 | 10.1 | 16.0 | PDF p. 7 |
| Underlying profit 3,4 margin% | 4.0 | 3.8 | 3.4 | 8.1 | PDF p. 7 |
| Net profit margin 7% | 3.1 | 3.3 | 2.0 | 6.8 | PDF p. 7 |
| Return on equity 8% | 9.6 | 8.2 | 6.6 | 18.4 | PDF p. 7 |
| Return on assets 9% | 4.9 | 3.9 | 3.4 | 9.3 | PDF p. 7 |
| Current ratio (times)times | 1.40 | 1.45 | 1.42 | 1.30 | PDF p. 7 |
| Debt to equity 10times | 0.57 | 0.69 | 0.59 | 0.57 | PDF p. 7 |
| Net debt to EBITDA 2,3times | 0.23 | 0.51 | 0.40 | 0.08 | PDF p. 7 |
| Receivable turnover 11 (days)days | 25 | 26 | 27 | 25 | PDF p. 7 |
| Inventory turnover 1,12 (days)days | 63 | 67 | 67 | 61 | PDF p. 7 |
| Other information | |||||
| Average CPO price - FOB Belawan (US$ per tonne)US$ per tonne | 1,093 | 1,005 | 901 | 1,248 | PDF p. 7 |
Original report: PDF p. 7 ↗
Comparative FY2024, FY2023 and FY2022 income statement values were restated for expense reclassification as footnote 1 says; restatement note applies to stated comparison context. p6 chart values were not reconstructed in this table.
Original physical page 7 footnotes 1–12 (two source columns, native extraction order retained): For comparative purpose, FY2024, FY2023 and FY2022 numbers were 5 Liquid working capital consists of trade receivables, inventories restated to reflect reclassification of certain expenses from selling (excluding consumables), advances and deposits to suppliers less trade expenses to cost of sales. There is no impact to EBITDA, operating profit, and trust receipts payables as well as advances and deposits from underlying profit, and net profit. customers 2 EBITDA = earnings before tax, non-controlling interests, interest on 6 Net debt = interest bearing debt less cash, short-term investments, and borrowings, depreciation and amortisation, net gain or loss from changes liquid working capital in fair value of biological assets, foreign exchange gain or loss, and 7 Attributable to owners of the Company exceptional items 8 Return on equity = underlying profit / equity attributable to owners of 3 Includes net fair value gain or loss on financial assets in accordance with the Company IFRS 9 9 Return on assets = underlying profit / total assets 4 Underlying profit = net profit attributable to owners of the Company 10 Debt to equity = interest bearing debt / total equity excluding net effect of net gain or loss from changes in fair value of 11 Receivable turnover = average trade receivables / revenue x 365 biological assets, depreciation of bearer plants, exceptional items, foreign 12 Inventory turnover = average inventory / cost of sales x 365 exchange gain or loss, and deferred tax expense
Units appear below each metric. Scroll to compare years
| Metric / unit | 2025Group | 2024Group | Source |
|---|---|---|---|
| RevenueUS$’000 | 12,951,478 | 10,909,719 | PDF p. 92 |
| Cost of salesUS$’000 | (11,051,851) | (9,342,396) | PDF p. 92 |
| Gross profitUS$’000 | 1,899,627 | 1,567,323 | PDF p. 92 |
| Operating expenses | |||
| Selling expensesUS$’000 | (704,132) | (561,967) | PDF p. 92 |
| General and administrative expensesUS$’000 | (405,386) | (393,917) | PDF p. 92 |
| SubtotalUS$’000 | (1,109,518) | (955,884) | PDF p. 92 |
| Operating ProfitUS$’000 | 790,109 | 611,439 | PDF p. 92 |
| Other income/(expenses) | |||
| Financial incomeUS$’000 | 59,806 | 70,232 | PDF p. 92 |
| Financial expensesUS$’000 | (218,559) | (243,451) | PDF p. 92 |
| Share of results of associated companiesUS$’000 | 4,266 | 5,166 | PDF p. 92 |
| Share of results of joint venturesUS$’000 | 25,713 | 14,976 | PDF p. 92 |
| Foreign exchange (loss)/gain, netUS$’000 | (3,438) | 36,354 | PDF p. 92 |
| Write-back of/(Provision for) expected credit loss on trade and non-trade receivables, netUS$’000 | 156 | (1,300) | PDF p. 92 |
| Other income, netUS$’000 | 5,606 | 63,843 | PDF p. 92 |
| SubtotalUS$’000 | (126,450) | (54,180) | PDF p. 92 |
| Profit before income taxUS$’000 | 663,659 | 557,259 | PDF p. 92 |
| Income taxUS$’000 | (221,366) | (145,164) | PDF p. 92 |
| Profit for the yearUS$’000 | 442,293 | 412,095 | PDF p. 92 |
| Attributable to | |||
| Owners of the CompanyUS$’000 | 400,198 | 364,552 | PDF p. 92 |
| Non-controlling interestsUS$’000 | 42,095 | 47,543 | PDF p. 92 |
| Attributable to owners of the Company and non-controlling interests | |||
| SubtotalUS$’000 | 442,293 | 412,095 | PDF p. 92 |
| Earnings per ordinary share | |||
| Basic and dilutedUS cents per share | 3.16 | 2.87 | PDF p. 92 |
Original report: PDF p. 92 ↗
2024 is marked Re-presented in the printed column heading.
Units appear below each metric. Scroll to compare years
| Metric / unit | 2025Group | 2024Group | Source |
|---|---|---|---|
| Profit for the yearUS$’000 | 442,293 | 412,095 | PDF p. 93 |
| Other comprehensive income | |||
| Net actuarial (loss)/gain on post-employment benefitsUS$’000 | (585) | 5,246 | PDF p. 93 |
| Share of other comprehensive income of joint venturesUS$’000 | (139) | 77 | PDF p. 93 |
| Changes in fair value of financial assets at fair value through other comprehensive incomeUS$’000 | (17,537) | (113,271) | PDF p. 93 |
| Foreign currency translation differences on consolidationUS$’000 | 2,098 | (23,534) | PDF p. 93 |
| Items that may be reclassified subsequently to profit or loss; share of other comprehensive income of | |||
| Joint venturesUS$’000 | (137) | (2,965) | PDF p. 93 |
| Associated companiesUS$’000 | (860) | (1,117) | PDF p. 93 |
| Other comprehensive income, net of income taxUS$’000 | (17,160) | (135,564) | PDF p. 93 |
| Total comprehensive income for the yearUS$’000 | 425,133 | 276,531 | PDF p. 93 |
| Attributable to | |||
| Owners of the CompanyUS$’000 | 391,208 | 233,128 | PDF p. 93 |
| Non-controlling interestsUS$’000 | 33,925 | 43,403 | PDF p. 93 |
| Total comprehensive income attributable to owners of the Company and non-controlling interests | |||
| SubtotalUS$’000 | 425,133 | 276,531 | PDF p. 93 |
Original report: PDF p. 93 ↗
2024 is marked Re-presented in the printed column heading.
Units appear below each metric. Scroll to compare years
| Metric / unit | 2025Group | 2024Group | Source |
|---|---|---|---|
| Current Assets | |||
| Cash and cash equivalentsUS$’000 | 523,401 | 435,924 | PDF p. 94 |
| Short-term investmentsUS$’000 | 621,053 | 563,903 | PDF p. 94 |
| Trade receivablesUS$’000 | 877,010 | 885,546 | PDF p. 94 |
| Other current assetsUS$’000 | 597,076 | 729,894 | PDF p. 94 |
| Biological assetsUS$’000 | 82,381 | 85,874 | PDF p. 94 |
| InventoriesUS$’000 | 1,854,215 | 1,950,294 | PDF p. 94 |
| SubtotalUS$’000 | 4,555,136 | 4,651,435 | PDF p. 94 |
| Non-current Assets | |||
| Long-term receivables and assetsUS$’000 | 55,449 | 49,100 | PDF p. 94 |
| Long-term investmentsUS$’000 | 1,533,631 | 1,484,992 | PDF p. 94 |
| Investment in associated companiesUS$’000 | 29,391 | 27,612 | PDF p. 94 |
| Investment in joint venturesUS$’000 | 266,077 | 246,442 | PDF p. 94 |
| Investment propertiesUS$’000 | 74 | 76 | PDF p. 94 |
| Property, plant and equipmentUS$’000 | 2,665,729 | 2,549,134 | PDF p. 94 |
| Bearer plantsUS$’000 | 1,241,732 | 1,284,615 | PDF p. 94 |
| Tax recoverableUS$’000 | 97,462 | 174,032 | PDF p. 94 |
| Deferred tax assetsUS$’000 | 70,051 | 82,835 | PDF p. 94 |
| Intangible assetsUS$’000 | 150,639 | 143,095 | PDF p. 94 |
| SubtotalUS$’000 | 6,110,235 | 6,041,933 | PDF p. 94 |
| Total AssetsUS$’000 | 10,665,371 | 10,693,368 | PDF p. 94 |
Original report: PDF p. 94 ↗
The statement continues from physical page 94 to physical page 95. Comparative amounts are as printed.
Units appear below each metric. Scroll to compare years
| Metric / unit | 2025Group | 2024Group | Source |
|---|---|---|---|
| Current Liabilities | |||
| Short-term borrowingsUS$’000 | 1,698,864 | 1,838,436 | PDF p. 95 |
| Bonds and notes payableUS$’000 | 87,992 | 116,084 | PDF p. 95 |
| Lease liabilitiesUS$’000 | 16,124 | 16,736 | PDF p. 95 |
| Trade and trust receipts payablesUS$’000 | 641,212 | 606,560 | PDF p. 95 |
| Other payablesUS$’000 | 719,744 | 573,107 | PDF p. 95 |
| Taxes payableUS$’000 | 95,892 | 57,225 | PDF p. 95 |
| SubtotalUS$’000 | 3,259,828 | 3,208,148 | PDF p. 95 |
| Non-current Liabilities | |||
| Long-term borrowingsUS$’000 | 1,120,436 | 1,470,649 | PDF p. 95 |
| Bonds and notes payableUS$’000 | 286,884 | 213,935 | PDF p. 95 |
| Lease liabilitiesUS$’000 | 38,619 | 49,679 | PDF p. 95 |
| Deferred tax liabilitiesUS$’000 | 148,151 | 157,357 | PDF p. 95 |
| Long-term payables and liabilitiesUS$’000 | 84,517 | 215,367 | PDF p. 95 |
| SubtotalUS$’000 | 1,678,607 | 2,106,987 | PDF p. 95 |
| Total LiabilitiesUS$’000 | 4,938,435 | 5,315,135 | PDF p. 95 |
| Equity Attributable to Owners of the Company | |||
| Issued capitalUS$’000 | 320,939 | 320,939 | PDF p. 95 |
| Share premiumUS$’000 | 1,216,095 | 1,216,095 | PDF p. 95 |
| Treasury sharesUS$’000 | (39,825) | (39,825) | PDF p. 95 |
| Other paid-in capitalUS$’000 | 184,318 | 184,318 | PDF p. 95 |
| Other reserves | |||
| Option reserveUS$’000 | 31,471 | 31,471 | PDF p. 95 |
| Currency translation reserveUS$’000 | (77,675) | (86,887) | PDF p. 95 |
| Fair value reserveUS$’000 | (437,111) | (419,574) | PDF p. 95 |
| PRC statutory reserveUS$’000 | 6,835 | 6,594 | PDF p. 95 |
| OthersUS$’000 | 45,892 | 46,557 | PDF p. 95 |
| Equity Attributable to Owners of the Company | |||
| SubtotalUS$’000 | (430,588) | (421,839) | PDF p. 95 |
| Retained earningsUS$’000 | 4,164,124 | 3,842,504 | PDF p. 95 |
| SubtotalUS$’000 | 5,415,063 | 5,102,192 | PDF p. 95 |
| Equity | |||
| Non-Controlling InterestsUS$’000 | 311,873 | 276,041 | PDF p. 95 |
| Total EquityUS$’000 | 5,726,936 | 5,378,233 | PDF p. 95 |
| Total Liabilities and EquityUS$’000 | 10,665,371 | 10,693,368 | PDF p. 95 |
Original report: PDF p. 95 ↗
The statement continues from physical page 94 to physical page 95. Comparative amounts are as printed.
Units appear below each metric. Scroll to compare years
| Metric / unit | 2025Group; Issued capital | 2025Group; Share premium | 2025Group; Treasury shares | 2025Group; Other paid-in capital | 2025Group; Other reserves | 2025Group; Retained earnings | 2025Group; Owners total | 2025Group; Non-controlling interests | 2025Group; Total equity | Source |
|---|---|---|---|---|---|---|---|---|---|---|
| Balance at beginning of year | ||||||||||
| Balance at 1.1.2025US$’000 | 320,939 | 1,216,095 | (39,825) | 184,318 | (421,839) | 3,842,504 | 5,102,192 | 276,041 | 5,378,233 | PDF p. 96 |
| Changes during year | ||||||||||
| Profit for the yearUS$’000 | - | - | - | - | - | 400,198 | 400,198 | 42,095 | 442,293 | PDF p. 96 |
| Other comprehensive incomeUS$’000 | - | - | - | - | (8,749) | (241) | (8,990) | (8,170) | (17,160) | PDF p. 96 |
| Total comprehensive income for the yearUS$’000 | - | - | - | - | (8,749) | 399,957 | 391,208 | 33,925 | 425,133 | PDF p. 96 |
| Dividends (Note 38)US$’000 | - | - | - | - | - | (78,337) | (78,337) | - | (78,337) | PDF p. 96 |
| Dividends paid to non-controlling shareholdersUS$’000 | - | - | - | - | - | - | - | (521) | (521) | PDF p. 96 |
| Capital subscribed by non-controlling shareholders (Note 42a)US$’000 | - | - | - | - | - | - | - | 2,428 | 2,428 | PDF p. 96 |
| Balance at end of year | ||||||||||
| Balance at 31.12.2025US$’000 | 320,939 | 1,216,095 | (39,825) | 184,318 | (430,588) | 4,164,124 | 5,415,063 | 311,873 | 5,726,936 | PDF p. 96 |
Original report: PDF p. 96 ↗
Each printed component column is preserved in source order. The 2024 balances are marked Re-presented in the source.
Units appear below each metric. Scroll to compare years
| Metric / unit | 2024Group; Issued capital | 2024Group; Share premium | 2024Group; Treasury shares | 2024Group; Other paid-in capital | 2024Group; Other reserves | 2024Group; Retained earnings | 2024Group; Owners total | 2024Group; Non-controlling interests | 2024Group; Total equity | Source |
|---|---|---|---|---|---|---|---|---|---|---|
| Balance at beginning of year | ||||||||||
| Balance at 1.1.2024US$’000 | 320,939 | 1,216,095 | (39,825) | 184,318 | (285,328) | 3,530,202 | 4,926,401 | 253,503 | 5,179,904 | PDF p. 96 |
| Changes during year | ||||||||||
| Profit for the yearUS$’000 | - | - | - | - | - | 364,552 | 364,552 | 47,543 | 412,095 | PDF p. 96 |
| Other comprehensive incomeUS$’000 | - | - | - | - | (131,119) | (305) | (131,424) | (4,140) | (135,564) | PDF p. 96 |
| Total comprehensive income for the yearUS$’000 | - | - | - | - | (131,119) | 364,247 | 233,128 | 43,403 | 276,531 | PDF p. 96 |
| Transfer upon dissolution of investmentUS$’000 | - | - | - | - | (5,392) | 5,392 | - | - | - | PDF p. 96 |
| Dividends (Note 38)US$’000 | - | - | - | - | - | (57,337) | (57,337) | - | (57,337) | PDF p. 96 |
| Dividends paid to non-controlling shareholdersUS$’000 | - | - | - | - | - | - | - | (20,865) | (20,865) | PDF p. 96 |
| Balance at end of year | ||||||||||
| Balance at 31.12.2024US$’000 | 320,939 | 1,216,095 | (39,825) | 184,318 | (421,839) | 3,842,504 | 5,102,192 | 276,041 | 5,378,233 | PDF p. 96 |
Original report: PDF p. 96 ↗
Each printed component column is preserved in source order. The 2024 balances are marked Re-presented in the source.
Units appear below each metric. Scroll to compare years
| Metric / unit | 2025Group | 2024Group | Source |
|---|---|---|---|
| Operating activities | |||
| Profit before income taxUS$’000 | 663,659 | 557,259 | PDF p. 97 |
| Adjustments for | |||
| Depreciation of investment propertiesUS$’000 | 5 | 5 | PDF p. 97 |
| Depreciation of property, plant and equipmentUS$’000 | 247,796 | 245,537 | PDF p. 97 |
| Depreciation of bearer plantsUS$’000 | 117,619 | 102,649 | PDF p. 97 |
| Amortisation of intangible assetsUS$’000 | 8,403 | 8,216 | PDF p. 97 |
| Net loss/(gain) from changes in fair value of biological assetsUS$’000 | 3,493 | (16,220) | PDF p. 97 |
| Unrealised foreign exchange loss/(gain)US$’000 | 9,284 | (43,860) | PDF p. 97 |
| Share of results of associated companiesUS$’000 | (4,266) | (5,166) | PDF p. 97 |
| Share of results of joint venturesUS$’000 | (25,713) | (14,976) | PDF p. 97 |
| Gain on disposal of a joint ventureUS$’000 | - | (32,030) | PDF p. 97 |
| Gain on disposal of an associated companyUS$’000 | - | (144) | PDF p. 97 |
| Negative goodwillUS$’000 | - | (202) | PDF p. 97 |
| Gain on disposal of property, plant and equipmentUS$’000 | (1,422) | (413) | PDF p. 97 |
| Impairment loss on goodwillUS$’000 | - | 14,576 | PDF p. 97 |
| Property, plant and equipment written offUS$’000 | 852 | 869 | PDF p. 97 |
| Trade receivables written offUS$’000 | 271 | - | PDF p. 97 |
| Non-trade receivables written offUS$’000 | 6 | 1,070 | PDF p. 97 |
| Expected credit loss provision/write-back | |||
| Trade receivables, netUS$’000 | (156) | (215) | PDF p. 97 |
| Non-trade receivables, netUS$’000 | - | 1,515 | PDF p. 97 |
| Adjustments for | |||
| Write-back of impairment loss on inventories, netUS$’000 | (1,516) | (990) | PDF p. 97 |
| Changes in fair value of financial assets at fair value through profit or lossUS$’000 | 4,639 | (17,551) | PDF p. 97 |
| Interest incomeUS$’000 | (59,806) | (70,232) | PDF p. 97 |
| Interest expenseUS$’000 | 214,065 | 240,354 | PDF p. 97 |
| Operating activities | |||
| Operating cash flows before working capital changesUS$’000 | 1,177,213 | 970,051 | PDF p. 97 |
| Changes in operating assets and liabilities | |||
| Trade receivablesUS$’000 | 8,403 | (231,510) | PDF p. 97 |
| Other current assetsUS$’000 | 124,461 | (148,758) | PDF p. 97 |
| InventoriesUS$’000 | 97,563 | (448,798) | PDF p. 97 |
| Trade and trust receipts payablesUS$’000 | 34,652 | 95,956 | PDF p. 97 |
| Other payablesUS$’000 | 27,371 | 83,674 | PDF p. 97 |
| Operating activities | |||
| Cash generated from operationsUS$’000 | 1,469,663 | 320,615 | PDF p. 97 |
| Interest paidUS$’000 | (220,530) | (239,804) | PDF p. 97 |
| Interest receivedUS$’000 | 60,333 | 74,143 | PDF p. 97 |
| Tax paidUS$’000 | (135,811) | (235,188) | PDF p. 97 |
| Net cash generated from/(used in) operating activitiesUS$’000 | 1,173,655 | (80,234) | PDF p. 97 |
Original report: PDF p. 97 ↗
Statement continues on physical page 98.
Units appear below each metric. Scroll to compare years
| Metric / unit | 2025Group | 2024Group | Source |
|---|---|---|---|
| Investing activities | |||
| Proceeds from disposal of property, plant and equipmentUS$’000 | 3,982 | 2,800 | PDF p. 98 |
| Proceeds from disposal of bearer plantsUS$’000 | 2,512 | 2,418 | PDF p. 98 |
| Capital expenditure on property, plant and equipmentUS$’000 | (355,458) | (264,173) | PDF p. 98 |
| Capital expenditure on bearer plantsUS$’000 | (63,813) | (62,974) | PDF p. 98 |
| Payments for investment in financial assetsUS$’000 | (193,630) | (339,164) | PDF p. 98 |
| Redemption/Return of capital from investment in financial assetsUS$’000 | 94,896 | 36,039 | PDF p. 98 |
| Proceeds from Plasma/KKPA program plantations, netUS$’000 | - | 1,449 | PDF p. 98 |
| Cash outflow from acquisition of subsidiaries, net of cash acquiredUS$’000 | - | (445) | PDF p. 98 |
| Return of capital from a joint ventureUS$’000 | 42 | - | PDF p. 98 |
| Proceeds from disposal of a joint ventureUS$’000 | - | 60,146 | PDF p. 98 |
| Proceeds from disposal of an associated companyUS$’000 | - | 310 | PDF p. 98 |
| Dividend received from joint venturesUS$’000 | 5,000 | 3,970 | PDF p. 98 |
| Dividend received from an associated companyUS$’000 | 1,666 | 1,231 | PDF p. 98 |
| Payments for intangible assetsUS$’000 | (16,196) | (2,419) | PDF p. 98 |
| Net increase in long-term receivables and assetsUS$’000 | (22,985) | (34,419) | PDF p. 98 |
| Net cash used in investing activitiesUS$’000 | (543,984) | (595,231) | PDF p. 98 |
| Financing activities | |||
| Proceeds from short-term borrowingsUS$’000 | 5,285,789 | 4,569,759 | PDF p. 98 |
| Proceeds from long-term borrowingsUS$’000 | 100,000 | 806,394 | PDF p. 98 |
| Proceeds from bonds and notes issueUS$’000 | 167,564 | - | PDF p. 98 |
| Payments of dividendsUS$’000 | (78,858) | (78,202) | PDF p. 98 |
| Payments of short-term borrowingsUS$’000 | (5,686,446) | (4,101,468) | PDF p. 98 |
| Payments of long-term borrowingsUS$’000 | (190,444) | (461,713) | PDF p. 98 |
| Payments of principal element of leasesUS$’000 | (16,554) | (21,862) | PDF p. 98 |
| Payments of bonds payableUS$’000 | (114,287) | (129,727) | PDF p. 98 |
| Capital subscribed by non-controlling shareholdersUS$’000 | 2,428 | - | PDF p. 98 |
| Payments of deferred bond and loan charges and bank loan administration costsUS$’000 | (1,817) | (3,705) | PDF p. 98 |
| (Increase)/Decrease in cash in banks and time deposits pledgedUS$’000 | (6,545) | 69,609 | PDF p. 98 |
| Net cash (used in)/generated from financing activitiesUS$’000 | (539,170) | 649,085 | PDF p. 98 |
| Cash and cash equivalents | |||
| Net increase/(decrease) in cash and cash equivalentsUS$’000 | 90,501 | (26,380) | PDF p. 98 |
| Cash and cash equivalents at the beginning of the yearUS$’000 | 278,596 | 317,633 | PDF p. 98 |
| Effect of exchange rate changes on cash and cash equivalentsUS$’000 | (9,569) | (12,657) | PDF p. 98 |
| Cash and cash equivalents at the end of the yearUS$’000 | 359,528 | 278,596 | PDF p. 98 |
Original report: PDF p. 98 ↗
Statement continues on physical page 98.
Units appear below each metric. Scroll to compare years
| Metric / unit | 2025Company | 2024Company | Source |
|---|---|---|---|
| Administrative expenses | |||
| Administrative expensesUS$’000 | (2,559) | (2,374) | PDF p. 181 |
| Other income/(expenses) | |||
| Interest incomeUS$’000 | 10 | 11 | PDF p. 181 |
| Foreign exchange (loss)/gain, netUS$’000 | (224) | 1,198 | PDF p. 181 |
| Loss before income taxUS$’000 | (2,773) | (1,165) | PDF p. 181 |
| Income taxUS$’000 | - | - | PDF p. 181 |
| Loss for the yearUS$’000 | (2,773) | (1,165) | PDF p. 181 |
| Other comprehensive income | |||
| Changes in fair value of equity instruments at fair value through other comprehensive incomeUS$’000 | (5,824) | (49,042) | PDF p. 181 |
| Other comprehensive incomeUS$’000 | (5,824) | (49,042) | PDF p. 181 |
| Total comprehensive income for the year, net of taxUS$’000 | (8,597) | (50,207) | PDF p. 181 |
Original report: PDF p. 181 ↗
Units appear below each metric. Scroll to compare years
| Metric / unit | 2025Company | 2024Company | Source |
|---|---|---|---|
| Current assets | |||
| Cash and cash equivalentsUS$’000 | 415 | 497 | PDF p. 182 |
| Other current assetsUS$’000 | 8,409 | 6,016 | PDF p. 182 |
| SubtotalUS$’000 | 8,824 | 6,513 | PDF p. 182 |
| Non-current assets | |||
| Interest in subsidiariesUS$’000 | 3,146,093 | 3,153,293 | PDF p. 182 |
| Long-term investmentsUS$’000 | 201,633 | 229,457 | PDF p. 182 |
| SubtotalUS$’000 | 3,347,726 | 3,382,750 | PDF p. 182 |
| Total AssetsUS$’000 | 3,356,550 | 3,389,263 | PDF p. 182 |
| Current liabilities | |||
| Accrued operating expensesUS$’000 | 391 | 2,020 | PDF p. 182 |
| Payable to third partiesUS$’000 | 7 | 6 | PDF p. 182 |
| Loans and advances from subsidiaries, unsecuredUS$’000 | 7,253 | 3,009 | PDF p. 182 |
| SubtotalUS$’000 | 7,651 | 5,035 | PDF p. 182 |
| Non-current liabilities | |||
| Loans and advances from subsidiaries, unsecuredUS$’000 | 69,946 | 18,341 | PDF p. 182 |
| Total LiabilitiesUS$’000 | 77,597 | 23,376 | PDF p. 182 |
| Equity | |||
| Issued capitalUS$’000 | 320,939 | 320,939 | PDF p. 182 |
| Share premiumUS$’000 | 1,850,965 | 1,850,965 | PDF p. 182 |
| Treasury sharesUS$’000 | (39,825) | (39,825) | PDF p. 182 |
| Other reserves | |||
| Option reserveUS$’000 | 31,471 | 31,471 | PDF p. 182 |
| Fair value reserveUS$’000 | (414,762) | (408,938) | PDF p. 182 |
| Equity | |||
| SubtotalUS$’000 | (383,291) | (377,467) | PDF p. 182 |
| Retained earningsUS$’000 | 1,530,165 | 1,611,275 | PDF p. 182 |
| SubtotalUS$’000 | 3,278,953 | 3,365,887 | PDF p. 182 |
| Total Liabilities and EquityUS$’000 | 3,356,550 | 3,389,263 | PDF p. 182 |
Original report: PDF p. 182 ↗
Units appear below each metric. Scroll to compare years
| Metric / unit | 2025Company; Issued capital | 2025Company; Share premium | 2025Company; Treasury shares | 2025Company; Other reserves | 2025Company; Retained earnings | 2025Company; Total equity | Source |
|---|---|---|---|---|---|---|---|
| Opening balance | |||||||
| Balance at 1 January 2025US$’000 | 320,939 | 1,850,965 | (39,825) | (377,467) | 1,611,275 | 3,365,887 | PDF p. 183 |
| Movements in year | |||||||
| Dividends (Note 16)US$’000 | - | - | - | - | (78,337) | (78,337) | PDF p. 183 |
| Loss for the yearUS$’000 | - | - | - | - | (2,773) | (2,773) | PDF p. 183 |
| Other comprehensive incomeUS$’000 | - | - | - | (5,824) | - | (5,824) | PDF p. 183 |
| Total comprehensive income for the yearUS$’000 | - | - | - | (5,824) | (2,773) | (8,597) | PDF p. 183 |
| Closing balance | |||||||
| Balance at 31 December 2025US$’000 | 320,939 | 1,850,965 | (39,825) | (383,291) | 1,530,165 | 3,278,953 | PDF p. 183 |
Original report: PDF p. 183 ↗
Units appear below each metric. Scroll to compare years
| Metric / unit | 2024Company; Issued capital | 2024Company; Share premium | 2024Company; Treasury shares | 2024Company; Other reserves | 2024Company; Retained earnings | 2024Company; Total equity | Source |
|---|---|---|---|---|---|---|---|
| Opening balance | |||||||
| Balance at 1 January 2024US$’000 | 320,939 | 1,850,965 | (39,825) | (328,425) | 1,669,777 | 3,473,431 | PDF p. 183 |
| Movements in year | |||||||
| Dividends (Note 16)US$’000 | - | - | - | - | (57,337) | (57,337) | PDF p. 183 |
| Loss for the yearUS$’000 | - | - | - | - | (1,165) | (1,165) | PDF p. 183 |
| Other comprehensive incomeUS$’000 | - | - | - | (49,042) | - | (49,042) | PDF p. 183 |
| Total comprehensive income for the yearUS$’000 | - | - | - | (49,042) | (1,165) | (50,207) | PDF p. 183 |
| Closing balance | |||||||
| Balance at 31 December 2024US$’000 | 320,939 | 1,850,965 | (39,825) | (377,467) | 1,611,275 | 3,365,887 | PDF p. 183 |
Original report: PDF p. 183 ↗
Units appear below each metric. Scroll to compare years
| Metric / unit | 2025Company | 2024Company | Source |
|---|---|---|---|
| Operating activities | |||
| Loss before income taxUS$’000 | (2,773) | (1,165) | PDF p. 184 |
| Adjustments | |||
| Interest incomeUS$’000 | (10) | (11) | PDF p. 184 |
| Operating activities | |||
| Operating cash flows before working capital changesUS$’000 | (2,783) | (1,176) | PDF p. 184 |
| Changes in operating assets and liabilities | |||
| Accrued operating expensesUS$’000 | (1,629) | 1,664 | PDF p. 184 |
| Payable to third partiesUS$’000 | 1 | - | PDF p. 184 |
| Other current assetsUS$’000 | (4) | (74) | PDF p. 184 |
| Operating activities | |||
| Cash (used in)/generated from operationsUS$’000 | (4,415) | 414 | PDF p. 184 |
| Interest receivedUS$’000 | 10 | 11 | PDF p. 184 |
| Net cash (used in)/generated from operating activitiesUS$’000 | (4,405) | 425 | PDF p. 184 |
| Investing activities | |||
| Advances to subsidiariesUS$’000 | (2,389) | (228) | PDF p. 184 |
| Return of capital from long-term investmentsUS$’000 | 23,000 | - | PDF p. 184 |
| Investment in long-term investmentsUS$’000 | (1,000) | (215,000) | PDF p. 184 |
| Net cash generated from/(used in) investing activitiesUS$’000 | 19,611 | (215,228) | PDF p. 184 |
| Financing activities | |||
| Proceeds from loans and advances from subsidiaries, netUS$’000 | 55,849 | 272,213 | PDF p. 184 |
| Proceeds from capital reduction in a subsidiaryUS$’000 | 7,200 | - | PDF p. 184 |
| Payment of dividendsUS$’000 | (78,337) | (57,337) | PDF p. 184 |
| Net cash (used in)/generated from financing activitiesUS$’000 | (15,288) | 214,876 | PDF p. 184 |
| Cash and cash equivalents | |||
| Net (decrease)/increase in cash and cash equivalentsUS$’000 | (82) | 73 | PDF p. 184 |
| Cash and cash equivalents at 1 JanuaryUS$’000 | 497 | 424 | PDF p. 184 |
| Cash and cash equivalents at 31 DecemberUS$’000 | 415 | 497 | PDF p. 184 |
Original report: PDF p. 184 ↗
Units appear below each metric. Scroll to compare years
| Metric / unit | 2025Group | 2024Group | 2023Group | 2022Group | Source |
|---|---|---|---|---|---|
| Financial highlights — original chart series | |||||
| RevenueUS$ million | 12,951 | 10,910 | 9,756 | 11,439 | PDF p. 6 |
| EBITDAUS$ million | 1,258 | 1,101 | 986 | 1,826 | PDF p. 6 |
| Net profit attributable to owners of the CompanyUS$ million | 400 | 365 | 198 | 782 | PDF p. 6 |
| Net margin% | 3.1 | 3.3 | 2.0 | 6.8 | PDF p. 6 |
| Dividend per shareS$ cents | 0.952 | 0.804 | 0.613 | 1.791 | PDF p. 6 |
| % to underlying profit% | 18 | 18 | 18 | 18 | PDF p. 6 |
| Interest bearing debtUS$ million | 3,249 | 3,706 | 3,065 | 2,984 | PDF p. 6 |
| Debt to equitytimes | 0.57 | 0.69 | 0.59 | 0.57 | PDF p. 6 |
| Net debt to EBITDAtimes | 0.23 | 0.51 | 0.40 | 0.08 | PDF p. 6 |
| Equity attributable to owners of the CompanyUS$ million | 5,415 | 5,102 | 4,926 | 5,001 | PDF p. 6 |
| Return on equity% | 9.6 | 8.2 | 6.6 | 18.4 | PDF p. 6 |
Original report: PDF p. 6 ↗
Original physical page 6 charts; years bound to x-aligned printed axes. EBITDA contains segment shading but only the printed total is provided numerically; segment amounts have not been inferred.
Where the money comes from
| Item / unit | 2025Plantations and palm oil mills | 2025Palm, laurics and others | 2025Eliminations | 2025Total | 2024Plantations and palm oil mills | 2024Palm, laurics and others | 2024Eliminations | 2024Total | Source |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||
| Revenue from external customersUS$'000 | 112,409 | 12,839,069 | - | 12,951,478 | 109,555 | 10,800,164 | - | 10,909,719 | PDF p. 150PDF p. 151 |
| Inter-segment salesUS$'000 | 2,346,272 | - | (2,346,272) | - | 2,064,266 | - | (2,064,266) | - | PDF p. 150PDF p. 151 |
| Total revenueUS$'000 | 2,458,681 | 12,839,069 | (2,346,272) | 12,951,478 | 2,173,821 | 10,800,164 | (2,064,266) | 10,909,719 | PDF p. 150PDF p. 151 |
| Results | |||||||||
| EBITDAUS$'000 | 708,761 | 550,483 | (766) | 1,258,478 | 567,381 | 534,373 | (308) | 1,101,446 | PDF p. 150PDF p. 151 |
| Other information | |||||||||
| Capital expenditureUS$'000 | 222,367 | 192,236 | - | 414,603 | 207,661 | 117,021 | - | 324,682 | PDF p. 150PDF p. 151 |
| Depreciation and amortisationUS$'000 | (260,606) | (113,217) | - | (373,823) | (241,031) | (115,376) | - | (356,407) | PDF p. 150PDF p. 151 |
| Write-back of expected credit loss on trade receivables, netUS$'000 | - | 156 | - | 156 | PDF p. 150 | ||||
| Trade and non-trade receivables written offUS$'000 | - | (277) | - | (277) | PDF p. 150 | ||||
| Net loss from changes in fair value of biological assetsUS$'000 | (3,493) | - | - | (3,493) | PDF p. 150 | ||||
| (Loss)/Gain from changes in fair value of financial assets at FVTPLUS$'000 | (4,645) | 6 | - | (4,639) | (4,109) | 21,660 | - | 17,551 | PDF p. 150PDF p. 151 |
| Interest on borrowingsUS$'000 | (67,592) | (146,473) | - | (214,065) | (77,471) | (162,883) | - | (240,354) | PDF p. 150PDF p. 151 |
| Other information - Share of profit of | |||||||||
| Associated companiesUS$'000 | 6 | 4,260 | - | 4,266 | PDF p. 150 | ||||
| Joint venturesUS$'000 | - | 25,713 | - | 25,713 | PDF p. 150 | ||||
| Assets | |||||||||
| Segment assetsUS$'000 | 4,491,526 | 5,912,356 | (1,435,111) | 8,968,771 | 4,284,711 | 5,849,163 | (1,112,636) | 9,021,238 | PDF p. 150PDF p. 151 |
| Assets - Investment in | |||||||||
| Associated companiesUS$'000 | 1,201 | 28,190 | - | 29,391 | 1,236 | 26,376 | - | 27,612 | PDF p. 150PDF p. 151 |
| Joint venturesUS$'000 | - | 266,077 | - | 266,077 | - | 246,442 | - | 246,442 | PDF p. 150PDF p. 151 |
| Liabilities | |||||||||
| Segment liabilitiesUS$'000 | (697,814) | (3,913,920) | 1,496,675 | (3,115,059) | (573,664) | (3,907,830) | 1,153,637 | (3,327,857) | PDF p. 150PDF p. 151 |
| Other information | |||||||||
| Non-trade receivables written offUS$'000 | - | (1,070) | - | (1,070) | PDF p. 151 | ||||
| Gain on disposal of a joint ventureUS$'000 | - | 32,030 | - | 32,030 | PDF p. 151 | ||||
| Impairment loss on goodwillUS$'000 | - | (14,576) | - | (14,576) | PDF p. 151 | ||||
| Other information - Share of (loss)/profit of | |||||||||
| Associated companiesUS$'000 | (93) | 5,259 | - | 5,166 | PDF p. 151 | ||||
| Joint venturesUS$'000 | - | 14,976 | - | 14,976 | PDF p. 151 | ||||
Two reportable segments: Plantations and palm oil mills; Palm, laurics and others. Unallocated lines printed only in Total column. Liabilities printed in parentheses.
Comparative year segment table. Unallocated lines printed only in Total column. Liabilities printed in parentheses.
| Item / unit | 2025Group | 2024Group | Source |
|---|---|---|---|
| Reconciliation | |||
| EBITDA for reportable segmentsUS$'000 | 1,259,244 | 1,101,754 | PDF p. 152 |
| Other EBITDAUS$'000 | (766) | (308) | PDF p. 152 |
| Net (loss)/gain from changes in fair value of biological assetsUS$'000 | (3,493) | 16,220 | PDF p. 152 |
| Depreciation and amortisationUS$'000 | (373,823) | (356,407) | PDF p. 152 |
| Foreign exchange (loss)/gainUS$'000 | (3,438) | 36,354 | PDF p. 152 |
| Interest on borrowingsUS$'000 | (214,065) | (240,354) | PDF p. 152 |
| Profit before income taxUS$'000 | 663,659 | 557,259 | PDF p. 152 |
A reconciliation of total EBITDA to total profit before income tax.
| Item / unit | 2025Group | 2024Group | Source |
|---|---|---|---|
| Revenue by geography | |||
| ChinaUS$'000 | 1,131,661 | 944,260 | PDF p. 152 |
| IndonesiaUS$'000 | 2,635,792 | 2,345,730 | PDF p. 152 |
| IndiaUS$'000 | 1,806,509 | 1,686,056 | PDF p. 152 |
| Rest of AsiaUS$'000 | 3,585,814 | 2,977,858 | PDF p. 152 |
| EuropeUS$'000 | 2,021,543 | 1,488,959 | PDF p. 152 |
| OthersUS$'000 | 1,770,159 | 1,466,856 | PDF p. 152 |
| Consolidated revenueUS$'000 | 12,951,478 | 10,909,719 | PDF p. 152 |
Revenue based on geographical location of customers.
| Item / unit | 2025Group | 2024Group | Source |
|---|---|---|---|
| Non-current non-financial assets | |||
| IndonesiaUS$'000 | 4,043,923 | 3,930,017 | PDF p. 152 |
| ChinaUS$'000 | 70,065 | 68,884 | PDF p. 152 |
| SingaporeUS$'000 | 156,967 | 155,348 | PDF p. 152 |
| IndiaUS$'000 | 68,660 | 69,938 | PDF p. 152 |
| OthersUS$'000 | 65,940 | 75,184 | PDF p. 152 |
| Total non-current non-financial assetsUS$'000 | 4,405,555 | 4,299,371 | PDF p. 152 |
Carrying amount of non-current non-financial assets, analysed by the geographical areas in which the assets are located.
Debt
| Item / unit | 2025Group, U.S. Dollar Equivalent US$'000, as at 31 December 2025 | Source |
|---|---|---|
| Long-term borrowings repayable in | ||
| 2026US$'000 | 430,976 | PDF p. 137 |
| 2027US$'000 | 462,870 | PDF p. 137 |
| 2028US$'000 | 437,817 | PDF p. 137 |
| 2029US$'000 | 200,443 | PDF p. 137 |
| ThereafterUS$'000 | 21,972 | PDF p. 137 |
| TotalUS$'000 | 1,554,078 | PDF p. 137 |
| Current portion (Note 28)US$'000 | (430,976) | PDF p. 137 |
| Non-current portionUS$'000 | 1,123,102 | PDF p. 137 |
Original currency columns (US$'000, S$'000, IDR'000) are also printed; only US$ equivalent captured here. 2025 original-currency totals: US$ 1,168,063; S$ 132,000; IDR 4,754,200,000.
| Item / unit | 2024Group, U.S. Dollar Equivalent US$'000, as at 31 December 2024 | Source |
|---|---|---|
| Long-term borrowings repayable in | ||
| 2025US$'000 | 174,537 | PDF p. 137 |
| 2026US$'000 | 397,543 | PDF p. 137 |
| 2027US$'000 | 418,640 | PDF p. 137 |
| 2028US$'000 | 433,264 | PDF p. 137 |
| ThereafterUS$'000 | 224,834 | PDF p. 137 |
| TotalUS$'000 | 1,648,818 | PDF p. 137 |
| Current portion (Note 28)US$'000 | (174,537) | PDF p. 137 |
| Non-current portionUS$'000 | 1,474,281 | PDF p. 137 |
Original currency columns also printed; only US$ equivalent captured.
| Item / unit | 2025Less than 1 year, US$'000 | 20251 to 5 years, US$'000 | 2025Over 5 years, US$'000 | 2025Total, US$'000 | 2024Less than 1 year, US$'000 | 20241 to 5 years, US$'000 | 2024Over 5 years, US$'000 | 2024Total, US$'000 | Source |
|---|---|---|---|---|---|---|---|---|---|
| At 31 December | |||||||||
| Short-term loansUS$'000 | 1,293,470 | - | - | 1,293,470 | 1,695,480 | - | - | 1,695,480 | PDF p. 157 |
| Long-term loansUS$'000 | 491,130 | 1,174,142 | 4,673 | 1,669,945 | 264,534 | 1,583,463 | 23,658 | 1,871,655 | PDF p. 157 |
| Bonds and notes payableUS$'000 | 109,021 | 323,944 | - | 432,965 | 136,658 | 229,223 | - | 365,881 | PDF p. 157 |
| Lease liabilitiesUS$'000 | 19,374 | 42,364 | 375 | 62,113 | 20,766 | 52,057 | 4,107 | 76,930 | PDF p. 157 |
Contractual undiscounted cash flows inclusive of principals and estimated interest.
| Item / unit | 2025US$'000 | 2024US$'000 | Source |
|---|---|---|---|
| Short-term loans | |||
| United States dollarUS$'000 | 1,036,496 | 1,372,052 | PDF p. 135 |
| Indian rupeeUS$'000 | 112,309 | 85,290 | PDF p. 135 |
| Japanese yenUS$'000 | 89,693 | 105,845 | PDF p. 135 |
| Indonesian rupiahUS$'000 | 26,798 | 100,251 | PDF p. 135 |
| EuroUS$'000 | 4,322 | 2,289 | PDF p. 135 |
| Short-term borrowings | |||
| Current maturities of long-term loansUS$'000 | 430,976 | 174,537 | PDF p. 135 |
| Less: Unamortised loan chargesUS$'000 | (1,730) | (1,828) | PDF p. 135 |
Certain time deposits, short-term investments, trade receivables, inventories, property, plant and equipment and bearer plants have been pledged to banks to obtain the Group’s secured short-term loans. No breach of loan covenants.
| Item / unit | 2025US$'000 | 2024US$'000 | Source |
|---|---|---|---|
| Short-term loans | |||
| Secured loansUS$'000 | 1,008,178 | 1,255,252 | PDF p. 135 |
| Unsecured loansUS$'000 | 261,440 | 410,475 | PDF p. 135 |
| Item / unit | 2025% per annum | 2024% per annum | Source |
|---|---|---|---|
| Short-term loan rates | |||
| United States dollar% | 4.67 | 5.74 | PDF p. 135 |
| Indian rupee% | 6.06 | 8.47 | PDF p. 135 |
| Japanese yen% | 0.63 | 0.28 | PDF p. 135 |
| Indonesian rupiah% | 5.74 | 5.75 | PDF p. 135 |
| Euro% | 3.66 | 4.77 | PDF p. 135 |
Short-term loans have a maturity period of up to 12 months from the end of the financial year.
| Item / unit | 2025US$'000 | 2024US$'000 | Source |
|---|---|---|---|
| Long-term loans | |||
| United States dollarUS$'000 | 1,168,063 | 1,194,075 | PDF p. 136 |
| Indonesian rupiahUS$'000 | 283,291 | 356,995 | PDF p. 136 |
| Singapore dollarUS$'000 | 102,724 | 97,748 | PDF p. 136 |
| Total long-term loansUS$'000 | 1,554,078 | 1,648,818 | PDF p. 136 |
| Less: Current maturities of long-term loansUS$'000 | (430,976) | (174,537) | PDF p. 136 |
| Less: Unamortised deferred loan chargesUS$'000 | (2,666) | (3,632) | PDF p. 136 |
| Non-current portionUS$'000 | 1,120,436 | 1,470,649 | PDF p. 136 |
Certain time deposits, trade receivables, inventories, property, plant and equipment and bearer plants have been pledged to banks to obtain the Group’s total secured loans.
| Item / unit | 2025US$'000 | 2024US$'000 | Source |
|---|---|---|---|
| Long-term loans | |||
| Secured loansUS$'000 | 1,350,194 | 1,427,022 | PDF p. 136 |
| Unsecured loansUS$'000 | 203,884 | 221,796 | PDF p. 136 |
| Item / unit | 2025% per annum | 2024% per annum | Source |
|---|---|---|---|
| Long-term loan rates | |||
| United States dollar% | 5.08 | 6.00 | PDF p. 136 |
| Indonesian rupiah% | 6.74 | 7.30 | PDF p. 136 |
| Singapore dollar% | 3.18 | 4.78 | PDF p. 136 |
| Item / unit | 2025US$'000 | 2024US$'000 | Source |
|---|---|---|---|
| Unsecured Indonesian rupiah Bonds | |||
| 9.00% p.a. fixed rate, due 2026US$'000 | 57,085 | 59,275 | PDF p. 138 |
| 9.25% p.a. fixed rate, due 2026US$'000 | 17,876 | 18,562 | PDF p. 138 |
| 9.50% p.a. fixed rate, due 2026US$'000 | 13,109 | 13,612 | PDF p. 138 |
| 8.00% p.a. fixed rate, due 2027US$'000 | 23,954 | 24,873 | PDF p. 138 |
| 8.25% p.a. fixed rate, due 2027US$'000 | 16,387 | 17,015 | PDF p. 138 |
| Less: Deferred bond chargesUS$'000 | (420) | (400) | PDF p. 138 |
| Unsecured Malaysian ringgit Islamic medium-term notes | |||
| 5.42% p.a. profit rate, due 2027US$'000 | 80,914 | 80,914 | PDF p. 138 |
| Bonds and notes payable | |||
| Less: Current portionUS$'000 | (87,992) | (116,084) | PDF p. 138 |
| Non-current portionUS$'000 | 286,884 | 213,935 | PDF p. 138 |
Bonds are unsecured Indonesian rupiah bonds; Islamic medium-term notes are unsecured, in Indonesian rupiah and Malaysian ringgit.
| Item / unit | 2025US$'000 | 2024US$'000 | Source |
|---|---|---|---|
| Lease liabilities | |||
| United States dollarUS$'000 | 51,391 | 62,752 | PDF p. 138 |
| Chinese renminbiUS$'000 | 1,246 | 1,716 | PDF p. 138 |
| EuroUS$'000 | 1,586 | 1,479 | PDF p. 138 |
| Indonesian rupiahUS$'000 | 378 | 340 | PDF p. 138 |
| OthersUS$'000 | 142 | 128 | PDF p. 138 |
| Total lease liabilitiesUS$'000 | 54,743 | 66,415 | PDF p. 138 |
| Less: Current portion of lease liabilitiesUS$'000 | (16,124) | (16,736) | PDF p. 138 |
| Non-current portionUS$'000 | 38,619 | 49,679 | PDF p. 138 |
The above lease liabilities include balances with related parties of US$365,000 (2024: US$179,000).
| Item / unit | 2025US$'000 | 2024US$'000 | Source |
|---|---|---|---|
| Capital risk management | |||
| Short-term borrowingsUS$'000 | 1,698,864 | 1,838,436 | PDF p. 154 |
| Long-term borrowingsUS$'000 | 1,120,436 | 1,470,649 | PDF p. 154 |
| Bonds and notes payableUS$'000 | 374,876 | 330,019 | PDF p. 154 |
| Lease liabilitiesUS$'000 | 54,743 | 66,415 | PDF p. 154 |
| Total debtsUS$'000 | 3,248,919 | 3,705,519 | PDF p. 154 |
| Item / unit | 2025carrying amount US$'000 | 2024carrying amount US$'000 | Source |
|---|---|---|---|
| Financial Liabilities | |||
| Variable rateUS$'000 | 2,842,040 | 3,206,681 | PDF p. 155 |
| Fixed rateUS$'000 | 689,404 | 704,186 | PDF p. 155 |
| Non-interest bearingUS$'000 | 633,063 | 689,439 | PDF p. 155 |
Financial Liabilities subsection only.
Payout
| Item | Value | Period / scope | Source |
|---|---|---|---|
| 11.3 Dividend Policy | The Company aims to declare future dividends of up to 30% of its underlying profit, i.e. profit attributable to owners of the Company after excluding net effect of net gain or loss from changes in fair value of biological assets and depreciation of bearer plants, exceptional items and other non-operating items. | Company | PDF p. 69 |
| Item | Value | Period / scope | Source |
|---|---|---|---|
| proposed final dividend | S$0.00952 | FY2025 final dividend proposed, per ordinary share | PDF p. 143 |
| Final dividend paid in respect of previous year of S$0.00804 (2024: S$0.00613) per share | S$0.00804 | Final dividend for FY2024, paid in 2025, per share | PDF p. 143 |
| Item | Value | Period / scope | Source |
|---|---|---|---|
| Dividend per share for the current year’s underlying profit (S$ cents) | 0.952 S$ cents | FY2025 | PDF p. 7 |
| Dividend per share change | 18% | FY2025 dividend as % of underlying profit | PDF p. 6 |
Extracted from Annual Report 2025 and checked against the cited pages; see the original report for full context.
Auditor’s report
| Item | Value | Period / scope | Source |
|---|---|---|---|
| Audit firm | Moore Stephens LLP | Group, FY2025 | PDF p. 91 |
| Engagement partner | Lao Mei Leng | Group, FY2025 | PDF p. 91 |
| Opinion | In our opinion, the accompanying consolidated financial statements give a true and fair view | Group, FY2025 | PDF p. 88 |
| Item | Value | Period / scope | Source |
|---|---|---|---|
| Valuation of investments in financial assets | The Group holds interests in its portfolio companies via various types of financial instruments, comprising quoted and unquoted equity securities, unquoted funds, convertible instruments and unquoted debt securities. | Group, FY2025 | PDF p. 88 |
| Accounting for derivative financial instruments | The Group enters into derivative financial instruments such as forward currency contracts and various commodity futures and options. | Group, FY2025 | PDF p. 89 |
| Item | Value | Period / scope | Source |
|---|---|---|---|
| Going concern | If we conclude that a material uncertainty exists, we are required to draw attention in our auditor’s report to the related disclosures | Group, FY2025 | PDF p. 90 |
Extracted from Annual Report 2025 and checked against the cited pages; see the original report for full context.
Group and parent company or bank figures are labelled separately. Parentheses indicate negative amounts; a dash and NA retain the report’s notation.
Comparative figures follow Annual Report 2025, including retrospective adjustments. Adjusted and reported earnings may have different definitions; refer to each statement’s notes.
Financial highlights provide four years, FY2022–FY2025. No fifth year has been inferred; historical original-report backfill remains separate and incomplete.
The primary statements preserve FY2025/FY2024 Group and Company scope, US$ thousands, every equity component and original cash-flow statement rows. Highlights use US$ millions with explicit cents, shares, ratios and other unit exceptions.
Unlabelled original subtotals remain unlabelled; source section headings provide context. Original repeated attribution totals are retained. Chart and table highlights can repeat the same disclosed metric.
Nineteen rows failed contiguous literal text-order checks; their exact original numbers, row labels, years, units and PDF coordinates were independently verified. Generic validator findings are retained in the audit provenance.
These tables show the available extracted figures. The original annual report contains the full statements, notes and definitions.